170 related articles for article (PubMed ID: 26206532)
1. Design characteristic of randomised controlled trials for geographic atrophy in age-related macular degeneration: selection of outcomes and sample size calculation.
Krezel AK; Hogg RE; Krezel S; Fallis R; Azuara-Blanco A
Eye (Lond); 2015 Nov; 29(11):1458-63. PubMed ID: 26206532
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes in randomised controlled trials on age-related macular degeneration.
Krezel AK; Hogg RE; Azuara-Blanco A
Br J Ophthalmol; 2015 Nov; 99(11):1560-4. PubMed ID: 25934846
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201
[TBL] [Abstract][Full Text] [Related]
5. Current practice in methodology and reporting of the sample size calculation in randomised trials of hip and knee osteoarthritis: a protocol for a systematic review.
Copsey B; Dutton S; Fitzpatrick R; Lamb SE; Cook JA
Trials; 2017 Oct; 18(1):466. PubMed ID: 29017518
[TBL] [Abstract][Full Text] [Related]
6. Improving Power and Sample Size Calculation in Rehabilitation Trial Reports: A Methodological Assessment.
Castellini G; Gianola S; Bonovas S; Moja L
Arch Phys Med Rehabil; 2016 Jul; 97(7):1195-201. PubMed ID: 26971671
[TBL] [Abstract][Full Text] [Related]
7. Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
Tulka S; Knippschild S; Funck S; Goetjes I; Uluk Y; Baulig C
PLoS One; 2021; 16(6):e0252640. PubMed ID: 34086796
[TBL] [Abstract][Full Text] [Related]
8. Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI.
Braakhekke M; Scholten I; Mol F; Limpens J; Mol BW; van der Veen F
Hum Reprod; 2017 Oct; 32(10):2117-2122. PubMed ID: 28938740
[TBL] [Abstract][Full Text] [Related]
9. Topical cyclosporine for atopic keratoconjunctivitis.
González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
[TBL] [Abstract][Full Text] [Related]
10. Validity of sample sizes in publications of randomised controlled trials on the treatment of age-related macular degeneration: cross-sectional evaluation.
Tulka S; Geis B; Baulig C; Knippschild S; Krummenauer F
BMJ Open; 2019 Oct; 9(10):e030312. PubMed ID: 31601589
[TBL] [Abstract][Full Text] [Related]
11. Sample size calculation in physical medicine and rehabilitation: a systematic review of reporting, characteristics, and results in randomized controlled trials.
Abdul Latif L; Daud Amadera JE; Pimentel D; Pimentel T; Fregni F
Arch Phys Med Rehabil; 2011 Feb; 92(2):306-15. PubMed ID: 21272730
[TBL] [Abstract][Full Text] [Related]
12. The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms.
Edwards SJ; Crawford F; van Velthoven MH; Berardi A; Osei-Assibey G; Bacelar M; Salih F; Wakefield V
Health Technol Assess; 2016 Dec; 20(94):1-224. PubMed ID: 28051764
[TBL] [Abstract][Full Text] [Related]
13. Sample size and number of outcome measures of veterinary randomised controlled trials of pharmaceutical interventions funded by different sources, a cross-sectional study.
Wareham KJ; Hyde RM; Grindlay D; Brennan ML; Dean RS
BMC Vet Res; 2017 Oct; 13(1):295. PubMed ID: 28978314
[TBL] [Abstract][Full Text] [Related]
14. The quality of the reported sample size calculations in randomized controlled trials indexed in PubMed.
Lee PH; Tse ACY
Eur J Intern Med; 2017 May; 40():16-21. PubMed ID: 27769569
[TBL] [Abstract][Full Text] [Related]
15. Anatomic Clinical Trial Endpoints for Nonexudative Age-Related Macular Degeneration.
Schaal KB; Rosenfeld PJ; Gregori G; Yehoshua Z; Feuer WJ
Ophthalmology; 2016 May; 123(5):1060-79. PubMed ID: 26952592
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
Mansouri A; Cooper B; Shin SM; Kondziolka D
J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
